These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2219573)

  • 1. Epidemiology of prostate cancer.
    Meikle AW; Smith JA
    Urol Clin North Am; 1990 Nov; 17(4):709-18. PubMed ID: 2219573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Etiology of prostate cancer and significance of screening for early prostate cancer].
    Imai K; Fukabori Y; Yamanaka H
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):403-6. PubMed ID: 8678489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The epidemiology of prostate cancer--recent trends in prostate cancer incidence and mortality].
    Sata F; Umemura T; Kishi R
    Gan To Kagaku Ryoho; 2001 Feb; 28(2):184-8. PubMed ID: 11242644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.
    Platz EA; Giovannucci E
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):237-53. PubMed ID: 15663987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostatic cancer: some epidemiological features.
    Donn AS; Muir CS
    Bull Cancer; 1985; 72(5):381-90. PubMed ID: 3878166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary aspects of prostate cancer.
    McLellan DL; Norman RW
    CMAJ; 1995 Oct; 153(7):895-900. PubMed ID: 7553490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
    Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
    Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidemiology of prostate cancer part II: the risk factors.
    Brawley OW; Knopf K; Thompson I
    Semin Urol Oncol; 1998 Nov; 16(4):193-201. PubMed ID: 9858325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cancer of the prostate. 1. Epidemiology].
    Mottet Auselo N; Costa P; Le Pellec L; Louis JF; Navratil H
    Prog Urol; 1995 Feb; 5(1):31-7. PubMed ID: 7536526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemiology of prostate cancer part I: descriptive epidemiology.
    Brawley OW; Knopf K; Merrill R
    Semin Urol Oncol; 1998 Nov; 16(4):187-92. PubMed ID: 9858324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancers of the prostate, penis, and testicles: epidemiology, prevention, and treatment.
    Stotts RC
    Nurs Clin North Am; 2004 Jun; 39(2):327-40. PubMed ID: 15159183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adenocarcinoma of the prostate].
    Dvorácek J
    Cas Lek Cesk; 1998 Aug; 137(17):515-21. PubMed ID: 9787503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiology of prostate cancer].
    Grosclaude P; Roumagnac M
    Ann Urol (Paris); 1992; 26(5):294-300. PubMed ID: 1485798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sociodemographic predictors of prostate cancer risk category at diagnosis: unique patterns of significant and insignificant disease.
    Dall'era MA; Hosang N; Konety B; Cowan JE; Carroll PR
    J Urol; 2009 Apr; 181(4):1622-7; discussion 1627. PubMed ID: 19230923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era.
    Konety BR; Bird VY; Deorah S; Dahmoush L
    J Urol; 2005 Nov; 174(5):1785-8; discussion 1788. PubMed ID: 16217287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Socio-economic and lifestyle factors associated with the risk of prostate cancer.
    Lund Nilsen TI; Johnsen R; Vatten LJ
    Br J Cancer; 2000 Apr; 82(7):1358-63. PubMed ID: 10755415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of subclinical cancers by prostate-specific antigen screening in asymptomatic men from high-risk prostate cancer families.
    Matikainen MP; Schleutker J; Mörsky P; Kallioniemi OP; Tammela TL
    Clin Cancer Res; 1999 Jun; 5(6):1275-9. PubMed ID: 10389909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasectomy and prostate cancer risk in China.
    Hsing AW; Wang RT; Gu FL; Lee M; Wang T; Leng TJ; Spitz M; Blot WJ
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):285-8. PubMed ID: 8061575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and patterns of self-initiated nutritional supplementation in men at high risk of prostate cancer.
    Uzzo RG; Brown JG; Horwitz EM; Hanlon A; Mazzoni S; Konski A; Greenberg RE; Pollack A; Kolenko V; Watkins-Bruner D
    BJU Int; 2004 May; 93(7):955-60. PubMed ID: 15142142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and the risk of prostate cancer.
    Porter MP; Stanford JL
    Prostate; 2005 Mar; 62(4):316-21. PubMed ID: 15389806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.